findmyKOL
Clinical trialNCT00224874CompletedPhase 2Interventional

Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)

SponsorNational Heart, Lung, and Blood Institute (NHLBI)Enrollment180Graft vs Host DiseaseImmune System Disorders
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Mary Horowitz, MD

    Center for International Blood and Marrow Transplant Research

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope National Medical Center

    Duarte, California, United States

  • University of California

    San Diego, California, United States

  • Stanford Hospital and Clinics

    Stanford, California, United States

  • University of Florida College of Medicine (shands)

    Gainesville, Florida, United States

  • Johns Hopkins/skccc

    Baltimore, Maryland, United States

  • Dfci/brigham & Women'S Hospital

    Boston, Massachusetts, United States

  • University of Michigan Medical Center

    Ann Arbor, Michigan, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • Washington University/barnes Jewish Hospital

    St Louis, Missouri, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Duke University Medical Center (peds)

    Durham, North Carolina, United States

  • University Hospitals of Cleveland/case Western

    Cleveland, Ohio, United States

  • Oregon Health Sciences University

    Portland, Oregon, United States

  • University of Pennsylvania Cancer Center

    Philadelphia, Pennsylvania, United States

  • University of Texas/md Anderson Crc

    Houston, Texas, United States

  • Texas Transplant Institute

    San Antonio, Texas, United States

  • Fred Hutchinson Cancer Research Center

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Sept 2005
Primary completion
31 Jan 2009
Completion
30 Jun 2012
Last update posted
1 Nov 2021
Registered enrollment
180
Registry id
NCT00224874

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.